This inventor holds 2 USPTO granted patents. Top assignee: Intron Biotechnology, Inc.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Ki Bong Oh: Innovator in Anticancer Peptide Compounds
Introduction
Ki Bong Oh is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of peptide compounds with potential anticancer properties. His work is characterized by a commitment to innovation and a focus on addressing critical health challenges.
Latest Patents
Ki Bong Oh holds 2 patents related to novel peptide compounds. His latest patents include a peptide compound, a production method therefor, and the use thereof. These patents provide a novel peptide compound that exhibits anticancer activity, making it a promising candidate for the prevention or treatment of cancer. The innovative methods of production and application of these compounds highlight his expertise in the field.
Career Highlights
Ki Bong Oh is currently associated with Intron Biotechnology, Inc., where he continues to advance his research and development efforts. His work at the company reflects his dedication to creating impactful solutions in biotechnology. His contributions have the potential to influence cancer treatment methodologies significantly.
Collaborations
Some of his notable coworkers include Jong Heon Shin and Lijuan Liao. Their collaborative efforts contribute to the innovative environment at Intron Biotechnology, Inc., fostering advancements in peptide research.
Conclusion
Ki Bong Oh's work in developing peptide compounds showcases his innovative spirit and commitment to improving health outcomes. His contributions to the field of biotechnology are paving the way for new treatments in cancer prevention and therapy.